These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6177851)

  • 21. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.
    Everett DW; Singhvi SM; DeForrest JM; Morrison RA; Weinstein SH; Migdalof BH
    Drug Des Deliv; 1987 Sep; 2(1):23-34. PubMed ID: 3509342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
    Levenson J; Simon A; Temmar M; Safar M
    Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
    Overlack A; Stumpe KO; Kühnert M; Heck I
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and pharmacology of angiotensin converting enzyme inhibitors.
    Antonaccio MJ
    J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
    Vandongen R; Tunney A; Martinez P
    Clin Sci (Lond); 1981 Apr; 60(4):387-92. PubMed ID: 7018794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
    Marks ES; Bing RF; Thurston H; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1981 Jun; 45(6):672-9. PubMed ID: 6165844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, SQ 29 852 in anesthetized dogs.
    Ohara N; Yokota S; Konishi C; Shukunobe K; Ono H
    J Pharmacobiodyn; 1991 Dec; 14(12):655-62. PubMed ID: 1812274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of captopril on the renal hemodynamics during aprotinin infusion in anesthetized dogs.
    Mizumura Y; Matsumoto M; Nishino A; Takata M; Iida H; Sugimoto T
    Ren Physiol; 1984; 7(5):299-303. PubMed ID: 6207570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart.
    Gondo M; Maruta H; Arakawa K
    Jpn Heart J; 1989 Mar; 30(2):219-29. PubMed ID: 2470929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between coronary occlusion and the renin-angiotensin system in the dog.
    Ertl G; Alexander RW; Kloner RA
    Basic Res Cardiol; 1983; 78(5):518-33. PubMed ID: 6360140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.